Modelling the impact on avoidable cardiovascular disease burden and costs of interventions to lower SBP in the England population

Journal of Hypertension

Volumn 30, Issue 1, 2012, Pages 217-226

  Dodhia, Hiten ^a   Phillips, Karen ^b   Zannou, Maria Irini ^c   Airoldi, Mara ^c   Bevan, Gwyn ^c  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b NHS Southwark and Kings College   (United Kingdom)

^c LONDON SCHOOL OF ECONOMICS   (United Kingdom)

Author keywords

avoidable burden; cost effectiveness; disability adjusted life years; heart disease; hypertension; modelling; stroke

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; COMPUTER MODEL; CONTROLLED STUDY; COST CONTROL; COST EFFECTIVENESS ANALYSIS; DEATH; DISABILITY; DRUG COST; FEMALE; HEALTH CARE COST; HEART DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUALITY OF LIFE; SENSITIVITY ANALYSIS; SIMULATION; SODIUM RESTRICTION; STROKE; SYSTOLIC BLOOD PRESSURE; UNITED KINGDOM;

EID: 83455202655     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0b013e32834d86ee     Document Type: Article

References (36)

1. Luengo-Fernández R, Leal J, Gray A, Petersen S, Rayner M. Cost of cardiovascular disease in the United Kingdom. Heart 2006; 92:1384-1389. (Pubitemid 44578822)
2. Messerli FH, Williams B, Ritz E. Essential hypertension. Lancet 2007; 370:591-603. (Pubitemid 47247855)
3. Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002; 360:1903-1913.
4. Dickinson HO, Mason JM, Nicolson DJ, Campbell F, Beyer FR, Cook JV, et al. Lifestyle interventions to reduce raised blood pressure: a systematic review of randomized controlled trials [Review] [168 refs]. J Hypertens 2006; 24:215-233.
5. NICE. NICE Clinical Guideline 34: hypertension: management of hypertension in adults in primary care. London: National Institute for Health and Clinical Excellence; 2006.
6. North of England Hypertension Guideline Development Group. Newcastle upon Tyne: Centre for Health Services Research, School of Population and Health Sciences, University of Newcastle upon Tyne; 2004. Report No. 111.
7. Jebb S, Mac Evilly C. Why 6 g? A summary of the scientific evidence for the salt intake target. London: Food Standards Agency and Medical Research Council; 2005.
8. Appel LJ, Moore TJ, Obarzanek E, Vollmer WM, Svetkey LP, Sacks FM, et al. A clinical trial of the effects of dietary patterns on blood pressure. N Engl J Med 1997; 336:1117-1124.
9. Sacks FM, Svetkey LP, Vollmer WM, Lawrence JA, Bray GA, Harsha D, et al. Effects on blood pressure of reduced dietary sodium and the dietary approaches to stop hypertension (DASH) diet. N Engl J Med 2001; 344:3-10. (Pubitemid 32064838)
10. Law MR, Morris JK, Wald NJ. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. Br Med J (Clinical research ed) 2009; 338:b1665.
11. Law M, Wald N, Morris J. Lowering blood pressure to prevent myocardial infarction and stroke: a new preventive strategy. Health Technol Assess 2003; 7.
12. Blake M, Chaudhury M, Deverill C, Doyle M, Erens B, Falaschetti E. Health survey for England 2003. London: TSO; 2004.
13. Primatesta P, Poulter NR. Improvement in hypertension management in England: results from the health survey for England [article]. J Hypertens 2006; 24:1193-1200.
14. Rothwell P, Coull A, Silver L, Fairhead J, Giles M, Lovelock CE, et al. Population-based study of event rate, incidence, case fatality, and mortality for all acute vascular events in all arterial territories (Oxford Vascular Study). Lancet 2005; 366:1773-1783. (Pubitemid 41642641)
15. Dennis MS, Burn JP, Sandercock PA, Bamford JM, Wade DT, Warlow CP. Long-term survival after first-ever stroke: the Oxfordshire Community Stroke Project. Stroke 1993; 24:796-800. (Pubitemid 23163551)
16. Law MR, Watt HC, Wald NJ. The underlying risk of death after myocardial infarction in the absence of treatment. Arch Intern Med 2002; 162:2405-2410. (Pubitemid 35340454)
17. Lawes CMM VHS, Law M, Elliott P. High blood pressure. In: Ezzati M, Lopez AD, Rodgers A, Murray CJL, editors. Comparative quantification of health risks: global and regional burden of disease attributable to selected major risk factors. Geneva, Switzerland: WHO; 2004.
18. Stouthard M, Essink-Bot M, Bonsel G, on behalf of the Dutch Disability Weights Group. Disability weights for diseases: a modified protocol and results for a Western European region. Eur J Public Health 2000; 10:24-30. (Pubitemid 30182899)
19. Melse J, Essink-Bot M, Kramers P, Hoeymans N, on behalf of the Dutch Burden of Disease Group. A national burden of disease calculation: Dutch disability-adjusted life-years. Am J Public Health 2000; 90:1241-1247. (Pubitemid 30497377)
20. NICE. Costing Report Implementing NICE guidance in England. NICE clinical guideline no. 34. London: National Institute for Health and Clinical Excellence; 2006.
21. Compiled by Lesly Curtis. Unit costs of health and social care 2007. Personal social services research unit, University of Kent 2007; 2007.
22. DH-PbR-Finance and costing team. Reference Costs Collection Guidance 2006-07. Department of Health; 2007.
23. McGuire, Wolf C, Saka O. Economic burden of stroke in England. London: Kings College and National Audit Office; 2006.
24. Russel LB, Siegel JE, Daniels N, Gold MR, Luce BR, Mandelblatt J. Costeffectiveness analysis as a guide to resource allocation in health: roles and limitations. In: Gold MR Seigel J, Russell L, Weinstein MC, editors. Costeffectiveness in health and medicine. New York: Oxford University Press; 1996.
25. Garber A, Phelps C. Economic foundations of cost-effectiveness analysis. J Health Econ 1997; 16:1-31. (Pubitemid 27224092)
26. NICE. Guide to the methods of technology appraisal. London: National Institute for Health and Clinical Excellence; 2008.
27. Bibbins-Domingo K, Chertow GM, Coxson PG, Moran A, Lightwood JM, Pletcher MJ, et al. Projected effect of dietary salt reductions on future cardiovascular disease. N Engl J Med 2010; 362:650-652.
28. Williams B, Poulter NR, Brown MJ, Davis M, McInnes GT, Potter JF, et al. British Hypertension Society guidelines for hypertension management 20#04 (BHS-IV): summary. Br Med J (Clinical research ed) 2004; 328:634-640. (Pubitemid 38340037)
29. Chobanian A, Bakris A, Black H, Cushman WC, Green LA, Izzo JL, et al. the National High Blood Pressure Education Programme Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. The JNC 7 Report. JAMA 2003; 289:2560-2572. (Pubitemid 37430158)
30. Mancia G. Blood pressure reduction and cardiovascular outcomes: past, present, and future. Am J Cardiol 2007; 100:3J-9J.
31. Wolf-maier K, Cooper RS, Kramer H, Banegas JR,Giampaoli S, Joffres MR, et al. Hypertension treatment and control in five European countries, Canada, and the United States. Hypertension 2004; 43:10-17. (Pubitemid 38031904)
32. Joint Health Surveys Unit. An assessment of dietary sodium levels among adults (aged 19-64) in the generalpopulation, based on analysis of dietary sodium in 24 h urine samples. http://www.food.gov.uk/science/dietarysurveys/ urinary. 2006. [Accessed 21 January 2008]
33. National Statistics. Health Survey for England: updating of trend tables to include 2006 data. The Information Centre 2008. [Accessed 1 February 2008]. http://www.ic.nhs.uk/statistics-and-data-collections/healthandlifestyles- related-surveys/health-survey-for-england/health-survey-forengland: -updating-of-trend-tables-to-include-2006-data.
34. Appel LJ, Brands MW, Daniels SR, Karanja N, Elmer PJ, Sacks FM. Dietary approaches to prevent and treat hypertension: a scientific statement from the American Heart Association. Hypertension 2006; 47:296-308. (Pubitemid 43189776)
35. Elmer PJ, Obarzanek E, Vollmer WM, Simons-Morton D, Stevens VJ, Young DR, et al. Effects of comprehensive lifestyle modification on diet, weight, physical fitness, and blood pressure control: 18-month results of a randomized trial. Ann Internal Med 2006; 144:485-495. (Pubitemid 46780671)
36. Selmer RM, Ivar Sønbø Kristiansen, Anton Haglerød, Graff-Iversen S, Larsen HK, Meyer HE, et al. Cost and health consequences of reducing the population intake of salt. J Epidemiol Commun Health 2000; 54:697-702. (Pubitemid 30639403)